CareDx, Inc. (CDNA)
67.15
+0.92
(+1.39%)
USD |
NASDAQ |
Oct 02, 16:00
67.30
+0.15
(+0.22%)
After-Hours: 20:00
CareDx Gross Profit Margin (Quarterly) : 73.37% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 73.37% |
| March 31, 2026 | 70.88% |
| December 31, 2025 | 66.62% |
| September 30, 2025 | 68.71% |
| June 30, 2025 | 66.19% |
| March 31, 2025 | 65.70% |
| December 31, 2024 | 66.75% |
| September 30, 2024 | 65.97% |
| June 30, 2024 | 68.98% |
| March 31, 2024 | 63.13% |
| December 31, 2023 | 59.96% |
| September 30, 2023 | 62.57% |
| June 30, 2023 | 62.31% |
| March 31, 2023 | 65.62% |
| December 31, 2022 | 63.54% |
| September 30, 2022 | 63.64% |
| June 30, 2022 | 65.17% |
| March 31, 2022 | 65.39% |
| December 31, 2021 | 65.54% |
| September 30, 2021 | 66.48% |
| June 30, 2021 | 67.15% |
| March 31, 2021 | 67.39% |
| December 31, 2020 | 67.12% |
| September 30, 2020 | 67.74% |
| June 30, 2020 | 63.10% |
| Date | Value |
|---|---|
| March 31, 2020 | 66.93% |
| December 31, 2019 | 63.38% |
| September 30, 2019 | 65.12% |
| June 30, 2019 | 62.45% |
| March 31, 2019 | 61.38% |
| December 31, 2018 | 54.45% |
| September 30, 2018 | 56.63% |
| June 30, 2018 | 58.44% |
| March 31, 2018 | 53.15% |
| December 31, 2017 | 52.90% |
| September 30, 2017 | 57.27% |
| June 30, 2017 | 55.26% |
| March 31, 2017 | 53.52% |
| December 31, 2016 | 40.30% |
| September 30, 2016 | 52.23% |
| June 30, 2016 | 43.10% |
| March 31, 2016 | 57.76% |
| December 31, 2015 | 62.61% |
| September 30, 2015 | 64.09% |
| June 30, 2015 | 64.82% |
| March 31, 2015 | 62.43% |
| December 31, 2014 | 70.42% |
| September 30, 2014 | 73.37% |
| June 30, 2014 | 64.54% |
| March 31, 2014 | 63.50% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Natera, Inc. | 63.70% |
| Caris Life Sciences, Inc. | 68.10% |
| Myriad Genetics, Inc. | 62.51% |
| BioRestorative Therapies, Inc. | -157.8% |
| Exagen, Inc. | 61.27% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 33.02% |
| Return on Assets | 24.72% |
| Return on Invested Capital | 30.71% |
| Profit Margin (Quarterly) | 83.85% |
| Operating Margin (Quarterly) | 0.19% |
| Return on Net Operating Assets | 57.35% |